Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade
Robert J. Motzer, Romain Banchereau, Habib Hamidi, Thomas Powles, David F. McDermott, Michael B. Atkins, Bernard Escudier, Lifen Liu, Ning Leng, Alexander R. Abbas, Jinzhen Fan, Hartmut Koeppen, Jennifer Lin, Susheela Carroll, Kenji Hashimoto, Sanjeev Mariathasan, Marjorie Green, Darren Tayama, Priti S. Hegde, Christina Schiff, Mahrukh Huseni, Brian I. Rini
Topics & Concepts
AngiogenesisAtezolizumabSunitinibCancer researchCDKN2AImmune checkpointRenal cell carcinomaBevacizumabBlockadeBiologyCancerMedicineNivolumabOncologyInternal medicineImmunotherapyReceptorChemotherapyRenal cell carcinoma treatmentCancer Genomics and DiagnosticsBladder and Urothelial Cancer Treatments